What is Exela Pharma Sciences?
Exela Pharma Sciences is an integrated specialty pharmaceutical company headquartered in Lenoir, North Carolina, established in 2005. The company specializes in the development and manufacturing of proprietary and generic sterile injectable products. Exela Pharma Sciences operates through two distinct business units: Finished Drug Products and Contract Development and Manufacturing Organization (CDMO), utilizing substantial cGMP sterile manufacturing capabilities. Their focus on addressing critical healthcare provider needs, enhancing patient outcomes, and mitigating drug shortages has solidified their reputation as a reliable partner within the pharmaceutical industry.
How much funding has Exela Pharma Sciences raised?
Exela Pharma Sciences has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Exela Pharma Sciences
PPP
Public-Private Partnership
What's next for Exela Pharma Sciences?
The recent strategic investment in Exela Pharma Sciences, following a substantial enterprise-level funding round, indicates a phase of accelerated growth and market expansion. This capital infusion is likely to bolster manufacturing capacity, support research and development initiatives for new sterile injectable products, and potentially expand their CDMO services to a broader client base. The company's established track record in quality and reliability, coupled with its focus on addressing drug shortages, positions it for continued success and strategic partnerships in the evolving pharmaceutical landscape.
See full Exela Pharma Sciences company page
